Healthcare Utilization in Liver Cirrhosis Patients, a Multicenter Retrospective Cohort Study

Last updated: December 5, 2024
Sponsor: Maastricht University Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Hyponatremia

Scar Tissue

Hepatic Fibrosis

Treatment

No intervention

Clinical Study ID

NCT06150482
2021-2857-A-2
  • Ages > 18
  • All Genders

Study Summary

Multicenter, retrospective cohort study investigating healthcare utilization in compensated and decompensated liver cirrhosis patients, including disease course and characteristics associated with healthcare utilization and, for example psychosocial factors.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients ≥ 18 years of age

  • Liver cirrhosis, based on biopsy, fibroscan or diagnostic imaging data

Exclusion

Exclusion Criteria:

  • Known malignancy with hepatic metastasis at baseline

  • Liver transplantation at baseline

Study Design

Total Participants: 600
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
December 31, 2024

Connect with a study center

  • Gelre Ziekenhuizen

    Apeldoorn, Gelderland 7334 DZ
    Netherlands

    Active - Recruiting

  • Maastricht University Medical Center

    Maastricht, Limburg 6202 AZ
    Netherlands

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.